NCM
KRRO icon

Nantahala Capital Management’s Korro Bio KRRO Stock Holding History

Nantahala Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7M Hold
660,036
– – 0.29% 85
2026
Q1 		$7.47M Buy
660,036
+60,036
+10% +$661K 0.28% 82
2025
Q4 		$4.81M Buy
+600,000
New +$14M 0.16% 101

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Nantahala Capital Management's KRRO Position: Q2 2026 in Review

Nantahala Capital Management held its Korro Bio (KRRO) position steady in Q2 2026 at 660,036 shares worth $8.7M. The position accounts for 0.29% of the portfolio, ranked #85.

Nantahala Capital Management first reported a position in KRRO in Q4 2025 and has held it in 3 quarters since. 107 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Nantahala Capital Management held 660,036 shares of Korro Bio worth $8.7M as of Q2 2026.
  • Nantahala Capital Management left its Korro Bio share count unchanged in Q2 2026.
  • Korro Bio made up 0.29% of Nantahala Capital Management's portfolio in Q2 2026, its #85 holding.
  • Nantahala Capital Management first reported a position in Korro Bio in Q4 2025 and has held it in 3 quarters since.
  • 107 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.